SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences - Quaterly Results

11 Nov 2024 Evaluate
The company witnessed a 10.04% growth in the revenue at Rs. 2269.12 millions for the quarter ended September 2024 as compared to Rs. 2062.14 millions during the year-ago period.The Net Loss for the quarter ended September 2024 is Rs. -726.23 millions as compared to Net Loss of Rs. -14.56 millions of corresponding quarter ended September 2023Operating Profit reported a sharp decline to 170.84 millions from 269.87 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 2269.12 2062.14 10.04 4088.24 3673.26 11.30 7732.62 7894.36 -2.05
Other Income 30.81 56.34 -45.31 48.61 116.46 -58.26 188.83 288.32 -34.51
PBIDT 170.84 269.87 -36.70 257.98 580.93 -55.59 460.13 1563.90 -70.58
Interest 179.18 151.02 18.65 315.35 271.49 16.16 543.26 569.42 -4.59
PBDT -971.01 118.85 -917.00 -1020.04 309.44 -429.64 -102.41 994.48 -110.30
Depreciation 134.36 124.09 8.28 261.29 242.06 7.94 493.90 328.21 50.48
PBT -1105.37 -5.24 20994.85 -1281.33 67.38 -2001.65 -596.31 666.27 -189.50
TAX -379.14 9.32 -4168.03 -418.31 24.14 -1832.85 -82.43 190.71 -143.22
Deferred Tax -433.57 7.36 -5990.90 -434.91 4.55 -9658.46 -82.43 51.51 -260.03
PAT -726.23 -14.56 4887.84 -863.02 43.24 -2095.88 -513.88 475.56 -208.06
Equity 167.50 167.46 0.02 167.50 167.46 0.02 167.47 157.09 6.61
PBIDTM(%) 7.53 13.09 -42.47 6.31 15.82 -60.10 5.95 19.81 -69.96

Camlin Fine Sciences Share Price

126.97 4.00 (3.25%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3640.10
Tata Chemicals 809.45
SRF 2519.20
Pidilite Inds. 1375.55
Deepak Nitrite 1736.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×